Intricate Metabolic Network for Paclitaxel Biosynthesis

Area of Science:

• Biochemistry
• Plant Molecular Biology
• Drug Discovery

Background:

• Paclitaxel is a vital anticancer drug derived from Taxus species.
• A high-quality Taxus genome map has accelerated research into paclitaxel biosynthesis.
• The formation of the oxetane ring, a key structural feature, remains a subject of debate regarding enzymatic mechanisms.

Purpose of the Study:

• To review recent progress in understanding paclitaxel biosynthesis.
• To highlight the elucidation of gene clusters for baccatin III production.
• To discuss challenges and future directions in heterologous biosynthesis of paclitaxel precursors.

Main Methods:

• Analysis of recent studies on paclitaxel biosynthetic pathways.
• Review of gene cluster identification for baccatin III.
• Examination of heterologous expression systems for pathway intermediates.

Main Results:

• Divergent hypotheses exist for oxetane ring formation enzymes (acetylation/epoxidation vs. epoxidation/acetylation).
• Gene clusters for baccatin III biosynthesis have been identified.
• Successful heterologous biosynthesis of baccatin III was achieved in tobacco via transient expression.
• Taxadiene 5α-hydroxylase (T5αH) showed varied activity in heterologous systems compared to native Taxus.

Conclusions:

• Elucidation of paclitaxel biosynthesis is advancing rapidly, particularly concerning baccatin III.
• Heterologous expression offers a viable route for producing key paclitaxel intermediates.
• Further research is needed to resolve enzymatic mechanisms and optimize heterologous systems for efficient drug production.